aluates Reports

$ 0.0

Automative

Global KRAS G12C Inhibitors Market Research Report 2024

Published Date: December 2024

Report Code: QYRE-Auto-30G18373

BUY CHAPTERS

Global KRAS G12C Inhibitors Market Research Report 2024

Code: QYRE-Auto-30G18373

Report

December 2024

Pages:76

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Amgen Inc

Innovent Biologics, Inc.

Mirati Therapeutics

Genfleet Therapeutics (Shanghai), Inc.

KRAS G12C Inhibitors Market Size

The global market for KRAS G12C Inhibitors was valued at US$ 130 million in the year 2023 and is projected to reach a revised size of US$ 2599 million by 2030, growing at a CAGR of 47.0% during the forecast period.

KRAS G12C Inhibitors Market

KARC G12C inhibitors are targeted therapeutics for G12C mutation, a specific mutation in the KRAS gene. KRAS gene mutations are prevalent in a variety of cancers, particularly in non-small cell lung cancer (NSCLC), where G12C mutations are a common driver. Its mechanism of action is to form covalent bonds with cysteine residues of the KRAS G12C mutant protein, locking KRAS in its inactive conformation and blocking its signaling, thereby inhibiting the proliferation of tumor cells. The development of this class of drugs offers a new therapeutic avenue for cancer patients carrying the KRAS G12C mutation, especially for those who are not sensitive to conventional chemotherapy.

North American market for KRAS G12C Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for KRAS G12C Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global manufacturers of KRAS G12C Inhibitors include Amgen, Innovent Biologics, Inc., Mirati Therapeutics, Genfleet Therapeutics (Shanghai), Inc., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for KRAS G12C Inhibitors, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding KRAS G12C Inhibitors.

The KRAS G12C Inhibitors market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global KRAS G12C Inhibitors market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the KRAS G12C Inhibitors manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of KRAS G12C Inhibitors Market Report

Report Metric	Details
Report Name	KRAS G12C Inhibitors Market
Accounted market size in year	US$ 130 million
Forecasted market size in 2030	US$ 2599 million
CAGR	47.0%
Base Year	year
Forecasted years	2024 - 2030
by Type	Garsorasib Fulzerasib Adagrasib Sotorasib
by Application	Hospital Clinic Others
Production by Region	North America Europe China Japan
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Amgen, Innovent Biologics, Inc., Mirati Therapeutics, Genfleet Therapeutics (Shanghai), Inc.
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of KRAS G12C Inhibitors manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of KRAS G12C Inhibitors in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is KRAS G12C Inhibitors Market growing?

Ans: The KRAS G12C Inhibitors Market witnessing a CAGR of 47.0% during the forecast period 2024-2030.

What is the KRAS G12C Inhibitors Market size in 2030?

Ans: The KRAS G12C Inhibitors Market size in 2030 will be US$ 2599 million.

Who are the main players in the KRAS G12C Inhibitors Market report?

Ans: The main players in the KRAS G12C Inhibitors Market are Amgen, Innovent Biologics, Inc., Mirati Therapeutics, Genfleet Therapeutics (Shanghai), Inc.

What are the Application segmentation covered in the KRAS G12C Inhibitors Market report?

Ans: The Applications covered in the KRAS G12C Inhibitors Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the KRAS G12C Inhibitors Market report?

Ans: The Types covered in the KRAS G12C Inhibitors Market report are Garsorasib, Fulzerasib, Adagrasib, Sotorasib

1 KRAS G12C Inhibitors Market Overview

1.1 Product Definition

1.2 KRAS G12C Inhibitors by Type

1.2.1 Global KRAS G12C Inhibitors Market Value Comparison by Type (2024-2030)

1.2.2 Garsorasib

1.2.3 Fulzerasib

1.2.4 Adagrasib

1.2.5 Sotorasib

1.3 KRAS G12C Inhibitors by Application

1.3.1 Global KRAS G12C Inhibitors Market Value by Application (2024-2030)

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Others

1.4 Global KRAS G12C Inhibitors Market Size Estimates and Forecasts

1.4.1 Global KRAS G12C Inhibitors Revenue 2019-2030

1.4.2 Global KRAS G12C Inhibitors Sales 2019-2030

1.4.3 Global KRAS G12C Inhibitors Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 KRAS G12C Inhibitors Market Competition by Manufacturers

2.1 Global KRAS G12C Inhibitors Sales Market Share by Manufacturers (2019-2024)

2.2 Global KRAS G12C Inhibitors Revenue Market Share by Manufacturers (2019-2024)

2.3 Global KRAS G12C Inhibitors Average Price by Manufacturers (2019-2024)

2.4 Global Key Players of KRAS G12C Inhibitors, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of KRAS G12C Inhibitors, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of KRAS G12C Inhibitors, Product Type & Application

2.7 Global Key Manufacturers of KRAS G12C Inhibitors, Date of Enter into This Industry

2.8 Global KRAS G12C Inhibitors Market Competitive Situation and Trends

2.8.1 Global KRAS G12C Inhibitors Market Concentration Rate

2.8.2 The Global 5 and 10 Largest KRAS G12C Inhibitors Players Market Share by Revenue

2.8.3 Global KRAS G12C Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global KRAS G12C Inhibitors Market Scenario by Region

3.1 Global KRAS G12C Inhibitors Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global KRAS G12C Inhibitors Sales by Region: 2019-2030

3.2.1 Global KRAS G12C Inhibitors Sales by Region: 2019-2024

3.2.2 Global KRAS G12C Inhibitors Sales by Region: 2025-2030

3.3 Global KRAS G12C Inhibitors Revenue by Region: 2019-2030

3.3.1 Global KRAS G12C Inhibitors Revenue by Region: 2019-2024

3.3.2 Global KRAS G12C Inhibitors Revenue by Region: 2025-2030

3.4 North America KRAS G12C Inhibitors Market Facts & Figures by Country

3.4.1 North America KRAS G12C Inhibitors Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America KRAS G12C Inhibitors Sales by Country (2019-2030)

3.4.3 North America KRAS G12C Inhibitors Revenue by Country (2019-2030)

3.4.4 United States

3.4.5 Canada

3.5 Europe KRAS G12C Inhibitors Market Facts & Figures by Country

3.5.1 Europe KRAS G12C Inhibitors Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe KRAS G12C Inhibitors Sales by Country (2019-2030)

3.5.3 Europe KRAS G12C Inhibitors Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific KRAS G12C Inhibitors Market Facts & Figures by Region

3.6.1 Asia Pacific KRAS G12C Inhibitors Market Size by Region: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific KRAS G12C Inhibitors Sales by Region (2019-2030)

3.6.3 Asia Pacific KRAS G12C Inhibitors Revenue by Region (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America KRAS G12C Inhibitors Market Facts & Figures by Country

3.7.1 Latin America KRAS G12C Inhibitors Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America KRAS G12C Inhibitors Sales by Country (2019-2030)

3.7.3 Latin America KRAS G12C Inhibitors Revenue by Country

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa KRAS G12C Inhibitors Market Facts & Figures by Country

3.8.1 Middle East and Africa KRAS G12C Inhibitors Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa KRAS G12C Inhibitors Sales by Country (2019-2030)

3.8.3 Middle East and Africa KRAS G12C Inhibitors Revenue by Country

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global KRAS G12C Inhibitors Sales by Type (2019-2030)

4.1.1 Global KRAS G12C Inhibitors Sales by Type (2019-2024)

4.1.2 Global KRAS G12C Inhibitors Sales by Type (2025-2030)

4.1.3 Global KRAS G12C Inhibitors Sales Market Share by Type (2019-2030)

4.2 Global KRAS G12C Inhibitors Revenue by Type (2019-2030)

4.2.1 Global KRAS G12C Inhibitors Revenue by Type (2019-2024)

4.2.2 Global KRAS G12C Inhibitors Revenue by Type (2025-2030)

4.2.3 Global KRAS G12C Inhibitors Revenue Market Share by Type (2019-2030)

4.3 Global KRAS G12C Inhibitors Price by Type (2019-2030)

5 Segment by Application

5.1 Global KRAS G12C Inhibitors Sales by Application (2019-2030)

5.1.1 Global KRAS G12C Inhibitors Sales by Application (2019-2024)

5.1.2 Global KRAS G12C Inhibitors Sales by Application (2025-2030)

5.1.3 Global KRAS G12C Inhibitors Sales Market Share by Application (2019-2030)

5.2 Global KRAS G12C Inhibitors Revenue by Application (2019-2030)

5.2.1 Global KRAS G12C Inhibitors Revenue by Application (2019-2024)

5.2.2 Global KRAS G12C Inhibitors Revenue by Application (2025-2030)

5.2.3 Global KRAS G12C Inhibitors Revenue Market Share by Application (2019-2030)

5.3 Global KRAS G12C Inhibitors Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Amgen

6.1.1 Amgen Company Information

6.1.2 Amgen Description and Business Overview

6.1.3 Amgen KRAS G12C Inhibitors Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Amgen KRAS G12C Inhibitors Product Portfolio

6.1.5 Amgen Recent Developments/Updates

6.2 Innovent Biologics, Inc.

6.2.1 Innovent Biologics, Inc. Company Information

6.2.2 Innovent Biologics, Inc. Description and Business Overview

6.2.3 Innovent Biologics, Inc. KRAS G12C Inhibitors Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Innovent Biologics, Inc. KRAS G12C Inhibitors Product Portfolio

6.2.5 Innovent Biologics, Inc. Recent Developments/Updates

6.3 Mirati Therapeutics

6.3.1 Mirati Therapeutics Company Information

6.3.2 Mirati Therapeutics Description and Business Overview

6.3.3 Mirati Therapeutics KRAS G12C Inhibitors Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Mirati Therapeutics KRAS G12C Inhibitors Product Portfolio

6.3.5 Mirati Therapeutics Recent Developments/Updates

6.4 Genfleet Therapeutics (Shanghai), Inc.

6.4.1 Genfleet Therapeutics (Shanghai), Inc. Company Information

6.4.2 Genfleet Therapeutics (Shanghai), Inc. Description and Business Overview

6.4.3 Genfleet Therapeutics (Shanghai), Inc. KRAS G12C Inhibitors Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Genfleet Therapeutics (Shanghai), Inc. KRAS G12C Inhibitors Product Portfolio

6.4.5 Genfleet Therapeutics (Shanghai), Inc. Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 KRAS G12C Inhibitors Industry Chain Analysis

7.2 KRAS G12C Inhibitors Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 KRAS G12C Inhibitors Production Mode & Process

7.4 KRAS G12C Inhibitors Sales and Marketing

7.4.1 KRAS G12C Inhibitors Sales Channels

7.4.2 KRAS G12C Inhibitors Distributors

7.5 KRAS G12C Inhibitors Customers

8 KRAS G12C Inhibitors Market Dynamics

8.1 KRAS G12C Inhibitors Industry Trends

8.2 KRAS G12C Inhibitors Market Drivers

8.3 KRAS G12C Inhibitors Market Challenges

8.4 KRAS G12C Inhibitors Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Amgen Inc

Innovent Biologics, Inc.

Mirati Therapeutics

Genfleet Therapeutics (Shanghai), Inc.

List of Tables

Table 1. Global KRAS G12C Inhibitors Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global KRAS G12C Inhibitors Market Value by Application (2024-2030) & (US$ Million)

Table 3. Global KRAS G12C Inhibitors Market Competitive Situation by Manufacturers in 2023

Table 4. Global KRAS G12C Inhibitors Sales (K Units) of Key Manufacturers (2019-2024)

Table 5. Global KRAS G12C Inhibitors Sales Market Share by Manufacturers (2019-2024)

Table 6. Global KRAS G12C Inhibitors Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global KRAS G12C Inhibitors Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market KRAS G12C Inhibitors Average Price (US$/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of KRAS G12C Inhibitors, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of KRAS G12C Inhibitors, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of KRAS G12C Inhibitors, Product Type & Application

Table 12. Global Key Manufacturers of KRAS G12C Inhibitors, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global KRAS G12C Inhibitors by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in KRAS G12C Inhibitors as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global KRAS G12C Inhibitors Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global KRAS G12C Inhibitors Sales by Region (2019-2024) & (K Units)

Table 18. Global KRAS G12C Inhibitors Sales Market Share by Region (2019-2024)

Table 19. Global KRAS G12C Inhibitors Sales by Region (2025-2030) & (K Units)

Table 20. Global KRAS G12C Inhibitors Sales Market Share by Region (2025-2030)

Table 21. Global KRAS G12C Inhibitors Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global KRAS G12C Inhibitors Revenue Market Share by Region (2019-2024)

Table 23. Global KRAS G12C Inhibitors Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global KRAS G12C Inhibitors Revenue Market Share by Region (2025-2030)

Table 25. North America KRAS G12C Inhibitors Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America KRAS G12C Inhibitors Sales by Country (2019-2024) & (K Units)

Table 27. North America KRAS G12C Inhibitors Sales by Country (2025-2030) & (K Units)

Table 28. North America KRAS G12C Inhibitors Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America KRAS G12C Inhibitors Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe KRAS G12C Inhibitors Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe KRAS G12C Inhibitors Sales by Country (2019-2024) & (K Units)

Table 32. Europe KRAS G12C Inhibitors Sales by Country (2025-2030) & (K Units)

Table 33. Europe KRAS G12C Inhibitors Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe KRAS G12C Inhibitors Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific KRAS G12C Inhibitors Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific KRAS G12C Inhibitors Sales by Region (2019-2024) & (K Units)

Table 37. Asia Pacific KRAS G12C Inhibitors Sales by Region (2025-2030) & (K Units)

Table 38. Asia Pacific KRAS G12C Inhibitors Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific KRAS G12C Inhibitors Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America KRAS G12C Inhibitors Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America KRAS G12C Inhibitors Sales by Country (2019-2024) & (K Units)

Table 42. Latin America KRAS G12C Inhibitors Sales by Country (2025-2030) & (K Units)

Table 43. Latin America KRAS G12C Inhibitors Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America KRAS G12C Inhibitors Revenue Market Share by Country (2019-2024)

Table 45. Middle East and Africa KRAS G12C Inhibitors Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East and Africa KRAS G12C Inhibitors Sales by Country (2019-2024) & (K Units)

Table 47. Middle East and Africa KRAS G12C Inhibitors Sales by Country (2025-2030) & (K Units)

Table 48. Middle East and Africa KRAS G12C Inhibitors Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East and Africa KRAS G12C Inhibitors Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global KRAS G12C Inhibitors Sales (K Units) by Type (2019-2024)

Table 51. Global KRAS G12C Inhibitors Sales (K Units) by Type (2025-2030)

Table 52. Global KRAS G12C Inhibitors Sales Market Share by Type (2019-2024)

Table 53. Global KRAS G12C Inhibitors Sales Market Share by Type (2025-2030)

Table 54. Global KRAS G12C Inhibitors Revenue (US$ Million) by Type (2019-2024)

Table 55. Global KRAS G12C Inhibitors Revenue (US$ Million) by Type (2025-2030)

Table 56. Global KRAS G12C Inhibitors Revenue Market Share by Type (2019-2024)

Table 57. Global KRAS G12C Inhibitors Revenue Market Share by Type (2025-2030)

Table 58. Global KRAS G12C Inhibitors Price (US$/Unit) by Type (2019-2024)

Table 59. Global KRAS G12C Inhibitors Price (US$/Unit) by Type (2025-2030)

Table 60. Global KRAS G12C Inhibitors Sales (K Units) by Application (2019-2024)

Table 61. Global KRAS G12C Inhibitors Sales (K Units) by Application (2025-2030)

Table 62. Global KRAS G12C Inhibitors Sales Market Share by Application (2019-2024)

Table 63. Global KRAS G12C Inhibitors Sales Market Share by Application (2025-2030)

Table 64. Global KRAS G12C Inhibitors Revenue (US$ Million) by Application (2019-2024)

Table 65. Global KRAS G12C Inhibitors Revenue (US$ Million) by Application (2025-2030)

Table 66. Global KRAS G12C Inhibitors Revenue Market Share by Application (2019-2024)

Table 67. Global KRAS G12C Inhibitors Revenue Market Share by Application (2025-2030)

Table 68. Global KRAS G12C Inhibitors Price (US$/Unit) by Application (2019-2024)

Table 69. Global KRAS G12C Inhibitors Price (US$/Unit) by Application (2025-2030)

Table 70. Amgen Company Information

Table 71. Amgen Description and Business Overview

Table 72. Amgen KRAS G12C Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 73. Amgen KRAS G12C Inhibitors Product

Table 74. Amgen Recent Developments/Updates

Table 75. Innovent Biologics, Inc. Company Information

Table 76. Innovent Biologics, Inc. Description and Business Overview

Table 77. Innovent Biologics, Inc. KRAS G12C Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 78. Innovent Biologics, Inc. KRAS G12C Inhibitors Product

Table 79. Innovent Biologics, Inc. Recent Developments/Updates

Table 80. Mirati Therapeutics Company Information

Table 81. Mirati Therapeutics Description and Business Overview

Table 82. Mirati Therapeutics KRAS G12C Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 83. Mirati Therapeutics KRAS G12C Inhibitors Product

Table 84. Mirati Therapeutics Recent Developments/Updates

Table 85. Genfleet Therapeutics (Shanghai), Inc. Company Information

Table 86. Genfleet Therapeutics (Shanghai), Inc. Description and Business Overview

Table 87. Genfleet Therapeutics (Shanghai), Inc. KRAS G12C Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 88. Genfleet Therapeutics (Shanghai), Inc. KRAS G12C Inhibitors Product

Table 89. Genfleet Therapeutics (Shanghai), Inc. Recent Developments/Updates

Table 90. Key Raw Materials Lists

Table 91. Raw Materials Key Suppliers Lists

Table 92. KRAS G12C Inhibitors Distributors List

Table 93. KRAS G12C Inhibitors Customers List

Table 94. KRAS G12C Inhibitors Market Trends

Table 95. KRAS G12C Inhibitors Market Drivers

Table 96. KRAS G12C Inhibitors Market Challenges

Table 97. KRAS G12C Inhibitors Market Restraints

Table 98. Research Programs/Design for This Report

Table 99. Key Data Information from Secondary Sources

Table 100. Key Data Information from Primary Sources

Table 101. Authors List of This Report

List of Figures

Figure 1. Product Picture of KRAS G12C Inhibitors

Figure 2. Global KRAS G12C Inhibitors Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global KRAS G12C Inhibitors Market Share by Type: 2023 & 2030

Figure 4. Garsorasib Product Picture

Figure 5. Fulzerasib Product Picture

Figure 6. Adagrasib Product Picture

Figure 7. Sotorasib Product Picture

Figure 8. Global KRAS G12C Inhibitors Market Value by Application (2024-2030) & (US$ Million)

Figure 9. Global KRAS G12C Inhibitors Market Share by Application: 2023 & 2030

Figure 10. Hospital

Figure 11. Clinic

Figure 12. Others

Figure 13. Global KRAS G12C Inhibitors Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global KRAS G12C Inhibitors Market Size (2019-2030) & (US$ Million)

Figure 15. Global KRAS G12C Inhibitors Sales (2019-2030) & (K Units)

Figure 16. Global KRAS G12C Inhibitors Average Price (US$/Unit) & (2019-2030)

Figure 17. KRAS G12C Inhibitors Report Years Considered

Figure 18. KRAS G12C Inhibitors Sales Share by Manufacturers in 2023

Figure 19. Global KRAS G12C Inhibitors Revenue Share by Manufacturers in 2023

Figure 20. Global 5 and 10 Largest KRAS G12C Inhibitors Players: Market Share by Revenue in KRAS G12C Inhibitors in 2023

Figure 21. KRAS G12C Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 22. Global KRAS G12C Inhibitors Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 23. North America KRAS G12C Inhibitors Sales Market Share by Country (2019-2030)

Figure 24. North America KRAS G12C Inhibitors Revenue Market Share by Country (2019-2030)

Figure 25. United States KRAS G12C Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 26. Canada KRAS G12C Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 27. Europe KRAS G12C Inhibitors Sales Market Share by Country (2019-2030)

Figure 28. Europe KRAS G12C Inhibitors Revenue Market Share by Country (2019-2030)

Figure 29. Germany KRAS G12C Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. France KRAS G12C Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. U.K. KRAS G12C Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. Italy KRAS G12C Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 33. Russia KRAS G12C Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 34. Asia Pacific KRAS G12C Inhibitors Sales Market Share by Region (2019-2030)

Figure 35. Asia Pacific KRAS G12C Inhibitors Revenue Market Share by Region (2019-2030)

Figure 36. China KRAS G12C Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. Japan KRAS G12C Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. South Korea KRAS G12C Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. India KRAS G12C Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. Australia KRAS G12C Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. China Taiwan KRAS G12C Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Southeast Asia KRAS G12C Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Latin America KRAS G12C Inhibitors Sales Market Share by Country (2019-2030)

Figure 44. Mexico KRAS G12C Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Brazil KRAS G12C Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Argentina KRAS G12C Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 47. Colombia KRAS G12C Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 48. Middle East and Africa KRAS G12C Inhibitors Sales Market Share by Country (2019-2030)

Figure 49. Middle East and Africa KRAS G12C Inhibitors Revenue Market Share by Country (2019-2030)

Figure 50. Turkey KRAS G12C Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 51. Saudi Arabia KRAS G12C Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 52. UAE KRAS G12C Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 53. Global Sales Market Share of KRAS G12C Inhibitors by Type (2019-2030)

Figure 54. Global Revenue Market Share of KRAS G12C Inhibitors by Type (2019-2030)

Figure 55. Global KRAS G12C Inhibitors Price (US$/Unit) by Type (2019-2030)

Figure 56. Global Sales Market Share of KRAS G12C Inhibitors by Application (2019-2030)

Figure 57. Global Revenue Market Share of KRAS G12C Inhibitors by Application (2019-2030)

Figure 58. Global KRAS G12C Inhibitors Price (US$/Unit) by Application (2019-2030)

Figure 59. KRAS G12C Inhibitors Value Chain

Figure 60. KRAS G12C Inhibitors Production Process

Figure 61. Channels of Distribution (Direct Vs Distribution)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-11W14373

Fri Dec 27 00:00:00 UTC 2024

Add to Cart

Global Hurthle Cell Carcinoma Treatment Market Insights, Forecast to 2030

120 Pages

Type: Report

Code: QYRE-Auto-35B1140

Fri Dec 27 00:00:00 UTC 2024

Add to Cart

Global Anaplastic Large Cell Lymphoma Drugs Market Insights, Forecast to 2030

120 Pages

Type: Report

Code: QYRE-Auto-27H888

Fri Dec 27 00:00:00 UTC 2024

Add to Cart

Global Anaplastic Large Cell Lymphoma Market Insights, Forecast to 2030

120 Pages

Type: Report

Code: QYRE-Auto-16R5994

Fri Dec 27 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global KRAS G12C Inhibitors Market Research Report 2024

Published Date: December 2024

Report Code: QYRE-Auto-30G18373

Global KRAS G12C Inhibitors Market Research Report 2024

FEATURED COMPANIES

KRAS G12C Inhibitors Market Size

KRAS G12C Inhibitors Market

Scope of KRAS G12C Inhibitors Market Report

Chapter Outline

FAQ for this report

How fast is KRAS G12C Inhibitors Market growing?

What is the KRAS G12C Inhibitors Market size in 2030?

Who are the main players in the KRAS G12C Inhibitors Market report?

What are the Application segmentation covered in the KRAS G12C Inhibitors Market report?

What are the Type segmentation covered in the KRAS G12C Inhibitors Market report?

FEATURED COMPANIES

RELATED REPORTS